Variable | On admission | Reference range |
White cell count | 7.2 | 4.2 – 9.1 10*3/uL |
Neutrophils | 49.6% | 34.0 – 67.9% |
Lymphocytes | 42.7% | 21.8 – 53.1 % |
Monocytes | 6.6% | 5.3 – 12.2 % |
Eosinophils | 0.1% | 0.8 – 7.0% |
Hemoglobin | 14.4 | 13.7 – 17.5 gm./dL |
Hematocrit | 47.5 | 40.1 – 51.0 % |
Platelet count | 344 | 150 – 450 10*3/uL |
MCV | 81.2 | 79.0 – 92.2 fL |
MCH | 24.6 | 25.7 – 32.2 pg |
MCHC | 30.3 | 32.3 – 36.5 gm/dL |
Sodium | 136 | 135 – 145 mEq/L |
Potassium | 4.0 | 3.5 – 5.3 mEq/L |
Chloride | 99 | 96 – 108 mEq/L |
Glucose | 92 | 70 – 99 mg/dL |
Calcium | 9.4 | 9.2 – 11.0 mg/dL |
Creatinine | 0.8 | 0.6 – 1.2 mg/dL |
ALT | 21 | 4 – 36 IU/L |
AST | 24 | 8 – 33 IU/L |
Bilirubin Total | 0.6 | 0.1 – 1.2 mg/dL |
Magnesium
|
1.7
|
1.3 – 2.1 mERespond to Reviewer- Case of LCV associated with Atorvastatin. q/L |
Complement C3 | 238 | 82 – 167 mg/dL |
Complement C4 | 33 | 12 – 38 mg/dL |
Antinuclear antibodies | Negative | Negative |
HIV AG/AB combo test | Non reactive | |
RPR | Non reactive | |
Rheumatoid factor | Negative | |
ESR | 96 | 0 – 30 mm/hr |
C-Reactive Protein | 3.68 | 0.00 – 1.0 mg/dL |
Hepatitis B surface Ab | Reactive – 33.05 | 0.00 – 12.00 m[IU]/mL |
Hepatitis B surface Ag | Non reactive | |
Hepatitis B core Ab | Non reactive | |
Hepatitis C surface Ag | Non reactive | |
Serum immunoglobulins | ||
IgA | 90 | 70–400 mg/dL |
IgG | 1000 | 700–1600 mg/dL |
IgM | 800 | 700–1600 mg/dL |
Serum electrophoresis | ||
Protein total | 7.0 | 6.0 - 8.5 g/dL |
Albumin | 4.0 | 2.9 - 4.4 g/dL |
Alpha-1 globulin | 0.2 | 0.0 - 0.4 g/dL |
Alpha-2 globulin | 0.7 | 0.4 - 1.0 g/dL |
Beta globulin | 0.8 | 0.7 - 1.3 g/dL |
Gamma globulin | 1.3 | 0.4 - 1.8 g/dL |
M-spike | Not observed | |
A/G Ratio | 1.3 | 0.7 - 1.7 |
ANCA Panel | ||
Cytoplasmic (C-ANCA) | <1:20 | Negative: <1:20 titer |
Perinuclear (P-ANCA) | <1:20 | Negative: <1:20 titer |
Atypical PANCA | <1:20 | Negative: <1:20 titer |
Antimyeloperoxidase abs (MPO) | <9.0 | 0.0 – 9.0 U/mL |
Antiproteinase 3 abs (PR-3) | <3.5 | 0.0 – 3.5 U/mL |